HealthQuad
VC Fund
Mehrauli, India
HealthQuad is a VC fund in Mehrauli focused on Health Care and Medical. HealthQuad’s investment philosophy is to create value by empowering visionary entrepreneurs building unique solutions that have the potential to redefine the way the society prevents and treats illness. Their approach is defined by “inspired ownership” and they strive to act as a meaningful strategic partner and not just as a financial sponsor.They provide a platform where entrepreneurs can work with us to get not only the capital but also the advice, support, and tools they need to achieve their market potential. In the eyes of the entrepreneurs, they see that the breadth and depth of their expertise, their strong network and their rich ecosystem, are their raison d’être for partnering with us.
- Total investments:
- 41
- Last investment:
- Lead investor:
- 51%
- Fund size:
- $162M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries HealthQuad invests in
Stages HealthQuad invests in
Countries HealthQuad invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Series A
- $5M–$20M
- Series B
- $15M–$33M
- Series C
- $40M–$75M
Investment Focus
Industry
- Health Care 18 (44%)
- Medical 5 (12%)
- Wellness 5 (12%)
- Hospital 4 (10%)
- Software 4 (10%)
Stage
- Series B 8 (20%)
- Series A 6 (15%)
- Series C 5 (12%)
- Venture - Series Unknown 4 (10%)
- Series D 3 (7%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Ajay Mahipal
Director
|
Director | Total investments: 6 | Find email | |
Abrar Mir
Co-Founder & Advisor
|
Co-Founder & Advisor | Total investments: 3 | Find email | |
|
Amit Varma
Co-Founder & Advisor
|
Co-Founder & Advisor | Total investments: 0 | Find email | |
Charles-Antoine Janssen
Co-Founder and Chief Investment Officer
|
Co-Founder and Chief Investment Officer | Total investments: 7 | Find email | |
|
Charles-Antoine Janssen
Co-Founder and Chief Investment Officer
|
Co-Founder and Chief Investment Officer | Total investments: 5 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Lifesigns is a healthcare company that offers real-time patient monitoring solutions. | Venture - Series Unknown / May 11, 2026 | ||
| ekincare is a patent-pending AI-powered integrated health benefits platform helping organizations and Employees with a Preventive, Predictive and Highly Personalised Healthcare solution.Trusted by many fortune 500 companies ekincare redefines healthcare by being India's first personal health assistant using technology, analytics, andcurated services.Our integrated platform provides access to a multitude of online and offline healthcare services such as 24*7 chat with a doc, health check-ups, medicines purchase and delivery, Health coach programs, Mental wellness programs, Gyms & Fitness services, etc | Series C / Apr 29, 2025 | ||
| Beta Drugs is a drug delivery system that differentiates itself and increases patient compliance. They promote patient compliance, are simple to use, prevent dosing mistakes, and reduce drug waste. They create and market sophisticated oncology medications. | $13.9M / Post-IPO Equity / Nov 28, 2024 | ||
| Redcliffe LifetechRedcliffe Lifesciences specializes in reproductive health testing, rare diseases, and cancer genetic diagnostics. The company offers a wide range of advanced products and services for healthcare companies, research institutions, and other public and private partnerships, such as testing using molecular and gene-based diagnostics,therapeutic molecules and advanced therapies, next-generation sequencing, and all bioinformatics services. | $42M / Series C / Sep 17, 2024 | ||
| At Qure.ai their mission is to make healthcare affordable and accessible using the power of artificial intelligence. They build deep learning solutions that aid physicians with routine diagnosis and treatment, allowing them to spend more time with patients. | $65M / Series D / Jun 25, 2024 | ||
| Stanplus Provides 24/7 emergency and medical transportation support.Their fleet 180+ Ambulances can support patients in 15 minutes across Hydrabad, eqquiped with ALS, BLS, Cardiac and Paitent transport Ambulance. | $20M / Series B / Apr 02, 2024 | ||
| CureSkin is a mobile application for derma-care. It is uses computer vision to recommend treatment to patients who don’t have access to trained professionals. | $20M / Series B / Mar 13, 2024 | ||
| GoApptiv offers end-to-end go-to-market solutions to pharmaceutical companies in India. Our proprietary data analytics tools combined with a network of distribution partners allows us to access these markets in the most cost effective and efficient way possible. HeathTech | Data Analytics | Phygital | Series B / Jan 31, 2024 | ||
| HealthifyMe is an application that allows its users to achieve their fitness and weight loss goals from their computers and smartphones.The application enables its users to track their calories, nutrition, and fitness activities; track their weight and determine if they are healthy; set healthy goals and work toward meeting them; share theirdata with experts; and get expert advice and suggestions on their lifestyles.HealthifyMe was developed and launched by a team of doctors, nutritionists, and fitness trainers in 2012. It is based in Bangalore, India. | $30M / Series D / Jun 07, 2023 | ||
| THB (stands for Technology | Healthcare | Big Data Analytics) is India’s leading clinical intelligence company. THB leverages real world evidence to empower the healthcare ecosystem with state-of-the-art clinical and business modules to improve patient outcomes. THB is on the mission to transform the healthcare industry from gut-based to data andevidence-based treatment and decisions.THB was founded in September 2015, and is headquartered in Gurugram (Haryana) with sales offices in 8 cities across India. Through its network, THB is currently spread across 50+ Indian cities in more than 12 states. | $20M / May 05, 2023 | ||
| See all 41 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does HealthQuad invest in?
HealthQuad invests primarily in Health Care, Medical and Wellness startups, most often at Series B and Series A stage. Most of the 41 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is HealthQuad's check size?
HealthQuad typically joins rounds of $5M–$20M at Series A, $15M–$33M at Series B and $40M–$75M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds HealthQuad participates in.
How do I contact HealthQuad?
Public channels for HealthQuad include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at HealthQuad?
The team at HealthQuad includes Ajay Mahipal (Director), Abrar Mir (Co-Founder & Advisor) and Amit Varma (Co-Founder & Advisor), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
